InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Garfield Alastair. Director active across 1 company, notably Rhythm Pharmaceuticals, INC.. Cumulatively, 6 disclosures have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €791k. Activity tracked since 13 August 2026. The latest transaction was filed on 13 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条